White paper on Ivermectin as a potential therapy for COVID-19

Indian J Tuberc. 2020 Jul;67(3):448-451. doi: 10.1016/j.ijtb.2020.07.031.


A group of senior doctors with vast clinical experience met on 19th July'20 under the aegis of Academy of Advanced Medical Education. The panel looked at Ivermectin, one of the old molecule and evaluated it's use in COVID 19 (Novel Coronavirus Disease 2019) management. After critical panel discussion, all the attending doctors came to a conclusion that Ivermectin can be a potential molecule for prophylaxis and treatment of people infected with Coronavirus, owing to its anti-viral properties coupled with effective cost, availability and good tolerability and safety.

Keywords: Antiviral; Coronavirus; Infection; PCR; Pandemic; SARS-CoV-2.

Publication types

  • Letter

MeSH terms

  • Antiparasitic Agents / therapeutic use
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Humans
  • Ivermectin / therapeutic use*
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Risk Factors
  • SARS-CoV-2
  • Treatment Outcome


  • Antiparasitic Agents
  • Ivermectin